The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival.
| Image |  |
|---|---|
| Description | scientific article published on 18 May 2018 |
| Author/s |
author: Urszula L McClurg |
| Publication date | May 18, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |